New medication for pneumonia with sepsis
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are in the hospital with suspected pneumonia (lung infection) that started before or within 48 hours of admission.
- You have signs of infection and inflammation, like fever, fast breathing, or abnormal white blood cell counts.
- You need extra oxygen to help you breathe.
- You have not been on a ventilator (breathing tube) yet.
- You do not have major kidney problems or a weakened immune system.
- If you are a woman who can have children, you must agree to use reliable birth control during the study and for 30 days after.
- You are not pregnant or breastfeeding.
- Your weight is not over 250 pounds.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
This trial studies whether a more detailed genetic test of lung fluids can find the exact cause of pneumonia in people whose first treatment isn't working, and help doctors choose a more effective treatment sooner.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This study tests whether an antibiotic called clarithromycin can help prevent additional infections in people who have sepsis from pneumonia. The goal is to see if it helps you recover faster and avoid complications.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.